HealthDay - FRIDAY, Aug. 17 (HealthDay News) -- The pain-relieving drug Zingo (lidocaine hydrochloride) has been approved by the U.S. Food and Drug Administration for children aged 3 to 18 who have "venous access" procedures such as IV insertions or blood draws, maker Anesiva Inc. said Friday.
More...
More...